FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 03:45:42 2024-06-06 pm EDT | ||
| 8.23 EUR | -11.03% |
|
| Current month | +40.36% | ||
| 1 month | +48.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 8.23 | -11.03% |
| 24-06-05 | 9.25 | +9.47% |
| 24-06-04 | 8.45 | +8.47% |
| 24-06-03 | 7.79 | +18.21% |
| 24-05-31 | 6.59 | +16.64% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 03:45 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD36BZ |
| ISIN | DE000HD36BZ3 |
| Date issued | 2024-02-28 |
| Strike | 203 $ |
| Maturity | Unlimited |
| Parity | 3.8 : 1 |
| Emission price | 11.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.96 € |
|---|---|
| Lowest since issue | 2.71 € |
| Spread | 0.07 € |
| Spread % | 0.87% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
236.7
USD
Average target price
284.6
USD
Spread / Average Target
+20.24%
- Stock Market
- Certificates
- Certificat
